Publication:
Antiretroviral therapy adherence among peripartum women with HIV in Kenya: an explanatory mixed methods study using dry blood spot measures and narrative interviews

dc.contributor.coauthorHampanda, K.
dc.contributor.coauthorGrubbs, H.
dc.contributor.coauthorCastillo-Mancilla, J.
dc.contributor.coauthorAnderson, P. L.
dc.contributor.coauthorThorne, J.
dc.contributor.coauthorHelova, A.
dc.contributor.coauthorOnono, M.
dc.contributor.coauthorAbuogi, L. L.
dc.contributor.kuauthorTuran, Janet Molzan
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.date.accessioned2024-12-29T09:36:11Z
dc.date.issued2024
dc.description.abstractAdherence to antiretroviral therapy (ART) remains sub-optimal among pregnant and postpartum women with HIV (PPWH) in high HIV prevalence low resource settings with few effective behavioral interventions. A large body of qualitative literature has established general barriers and facilitators to ART adherence in PPWH at various levels (individual, interpersonal, structural). However, research exploring the underlying behavioral mechanisms of ART adherence in PPWH with objectively verified adherence biomarkers is extremely limited. We conducted 24 in-depth interviews with postpartum women in western Kenya who had linked ART drug concentrations obtained from three dried blood spot samples across the peripartum period. Among PPWH with a low drug concentration (n = 13) compared to those with continuously high drug concentrations (n = 11), distinct themes emerged related to HIV status disclosure, social support, interactions with the health system, and health beliefs. By combining ART biomarkers with patient reported challenges, there is the potential for real-time interventions to support sustained ART adherence among PPWH and improve maternal and infant health outcomes.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue12
dc.description.publisherscopeInternational
dc.description.sponsorsThis work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development: [Grant Number R01 HD080477-04S1];National Institute of Allergy and Infectious Diseases: [Grant Number T32AI007447].
dc.description.volume36
dc.identifier.doi10.1080/09540121.2024.2383885
dc.identifier.eissn1360-0451
dc.identifier.issn0954-0121
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85200592374
dc.identifier.urihttps://doi.org/10.1080/09540121.2024.2383885
dc.identifier.urihttps://hdl.handle.net/20.500.14288/21979
dc.identifier.wos1285328800001
dc.keywordsAntiretroviral therapy
dc.keywordsPrevention of mother-to-child transmission
dc.keywordsTenofovir-diphosphate
dc.keywordsDry blood spot
dc.keywordsSub-Saharan Africa
dc.languageen
dc.publisherTaylor & Francis, Routledge
dc.sourceAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
dc.subjectHuman immunodeficiency virus
dc.subjectVertical transmission
dc.subjectNeonatal infant
dc.titleAntiretroviral therapy adherence among peripartum women with HIV in Kenya: an explanatory mixed methods study using dry blood spot measures and narrative interviews
dc.typeJournal article
dc.type.otherEarly access
dspace.entity.typePublication
local.contributor.kuauthorTuran, Janet Molzan

Files